Preparation method and use of cell-derived nanovesicles
By improving the cell-derived nanovesicle preparation method, and combining low-speed centrifugation and protective extraction solution, the problems of easy damage and poor stability of vesicles in the existing technology have been solved, and efficient and stable nanovesicle preparation has been achieved for promoting tissue repair and skin care.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 江苏赛亿生物技术有限公司
- Filing Date
- 2026-03-16
- Publication Date
- 2026-06-16
AI Technical Summary
Existing technologies for isolating and purifying extracellular vesicles (EVs) from complex biological systems suffer from low efficiency, limited scale, vesicle susceptibility to damage, and difficulty in balancing high yield and high stability. In particular, when obtaining specific subpopulations (such as 30-150nm EVs), traditional methods such as ultracentrifugation can lead to vesicle rupture, fusion, or leakage of contents.
A method for preparing cell-derived nanovesicles was adopted, which included physically disrupting umbilical cord mesenchymal stem cells and mixing them with PEG-6000, sodium chloride and protective additives. After standing, the mixture was centrifuged at low speed and combined with a PEG-sodium chloride precipitation system to avoid ultra-high speed centrifugation. Squalane and ceramide lipids were used to protect the vesicle membrane and construct a stable extraction system.
The obtained nanovesicles have uniform particle size, good membrane integrity, and high bioactivity. They can promote the proliferation and migration of human skin fibroblasts, significantly improve the yield and stability of vesicles, and are suitable for pharmaceutical compositions and skin care products. They have good skin biocompatibility and safety, and promote wound repair.
Smart Images

Figure CN121896162B_ABST